Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Matthews

Showing results (291-300 of 293) with videos related to

Pageof 30
Sort By:
You have reached the last page of results.This site can display upto 293 results.
Nature Microbiology|May 31, 2022
Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in AustraliaAnupriya Aggarwal, Alberto Ospina Stella, Gregory Walker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2026
Ensitrelvir for the treatment of hospitalized adults with COVID-19: an international phase 3 randomized placebo-controlled trialJason V Baker, Lianne Siegel, Marcelo Losso, et al.
The New England Journal of Medicine|June 17, 2026
Cefazolin for Methicillin-Susceptible <i>Staphylococcus aureus</i> Bacteremia, Todd C Lee, Lauren A Barina, et al.
Pageof 30

Showing results (291-300 of 293) with videos related to

Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 293 results.
Nature Microbiology|May 31, 2022
Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in AustraliaAnupriya Aggarwal, Alberto Ospina Stella, Gregory Walker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2026
Ensitrelvir for the treatment of hospitalized adults with COVID-19: an international phase 3 randomized placebo-controlled trialJason V Baker, Lianne Siegel, Marcelo Losso, et al.
The New England Journal of Medicine|June 17, 2026
Cefazolin for Methicillin-Susceptible <i>Staphylococcus aureus</i> Bacteremia, Todd C Lee, Lauren A Barina, et al.
Pageof 30